drugset / Trial / NCT06826742
Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if there is a difference in opioid requirements at 0-48 hours after scheduled cesarean delivery in patients receiving 150 mcg intrathecal morphine compared to 0.2 mg/kg (maximum 20 mg) intravenous methadone.
Timeline
- Start
- 2025-02-12
- Primary completion
- 2025-09-14
- Completion
- 2025-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methadone | Other / unclassified | 0.2 mg/kg | Intravenous |
| Comparator | Morphine | Other / unclassified | 150 ug | Intrathecal |
Indications
No indication recorded.